Tough crowd, geez.
Oral presentation (by whom, i wonder?) and a poster presentation that will highlight Vaxinia and the complete response in a bile duct cancer patient, in front of all of the cholangiocarcinoma experts. Worth also nothing there is (still?) a 2nd patient on study for cholangio, that by now will have been on study (if they remained on study) for a further 120+ days. Will we see our 2nd CR?
GLTAH
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference, page-12
-
- There are more pages in this discussion • 210 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $384.2K | 7.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 1723946 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 905438 | 6 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |